Cohance Lifesciences Limited Cohance Lifesciences Limited

Cohance Lifesciences Limited

COHANCE

Rangering i aksjer #6338
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Aksjekurs
$5.09
Markedsverdi
$1.95B
Endring (1 dag)
0.79%
Endring (1 år)
-57.07%
Land
IN
Handel Cohance Lifesciences Limited (COHANCE)

Kategori

Healthcare
Historikk for aksjesplitt for Cohance Lifesciences Limited (COHANCE)
Aksjen Cohance Lifesciences Limited (symbol: COHANCE) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én COHANCE-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 COHANCE-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter